PDCD1LG2 and neoplasm: Recently, several researches have discovered that tumor cells can evade anti-tumor immunity by modulating T cell-activated immunity response mechanisms, and many immunity response related molecules participate in such causal link, like CTLA-4, PD-1 and its ligands PD-L1 and PD-L2 (13).